Send me a link:

*Text messaging rates may apply.

 Dow Down 0.02% Nasdaq Down 0.04%

Biogen Idec Inc. (BIIB)

-NasdaqGS
336.79 0.81(0.24%) Jul 24, 3:59PM EDT
Prev Close:337.60
Open:337.60
Bid:332.09 x 100
Ask:344.00 x 100
1y Target Est:360.62
Beta:1.23
Next Earnings Date:N/A
Day's Range:335.22 - 339.83
52wk Range:203.55 - 358.89
Volume:1,599,871
Avg Vol (3m):1,197,640
Market Cap:79.89B
P/E (ttm):41.89
EPS (ttm):8.04
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBDown 0.24%79.89B
PFE193.53B

Key Statistics

Forward P/E (1 yr):21.36
P/S (ttm):10.47
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :12.69
Quarterly EPS Est (Sep-14) :3.35
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.25

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of multiple sclerosis (MS), neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback